Related Experiment Videos

Topics in dose-response modeling

M Coleman1, H Marks

  • 1Office of Public Health and Science, U.S. Department of Agriculture, Washington, D.C. 20250-3700, USA. peg.coleman@usda.gov

Journal of Food Protection
|November 26, 1998
PubMed

Insights

Quantitative microbial risk assessment faces challenges due to limited data for dose-response modeling. This study explores methods to address uncertainty and variability in predicting illness probability from microbial pathogens.

Area of Science:

  • Microbiology
  • Risk Assessment
  • Epidemiology

Background:

  • Conducting dose-response assessments for microbial pathogens is challenging due to limited supporting data for quantitative modeling.
  • The probability of illness is influenced by complex interactions between host, pathogen, and environmental factors (disease triangle).

Purpose of the Study:

  • To develop and present methodologies for microbial risk assessment, focusing on dose-response and exposure modeling.
  • To illustrate key issues in dose-response modeling impacting risk estimation and uncertainty analysis.
  • To propose criteria for developing surrogate dose-response models for pathogens lacking human data.

Main Methods:

  • Utilizing data analysis and formal inferencing to construct dose-response and exposure models.
  • Applying the epidemiological triangle to understand host-pathogen-environment interactions in modeling.
  • Evaluating various dose-response model forms (e.g., exponential, Beta-Poisson, probit, logistic, Gompertz) and distinguishing uncertainty from variability.

Main Results:

  • Demonstrating the impact of variability and uncertainty on pathogen characteristics and human response.
  • Highlighting the risk of underestimating uncertainty if alternative models are not considered.
  • Presenting biologically plausible alternative dose-response models for illness prediction.

Conclusions:

  • Distinguishing between uncertainty and variability is critical for accurate microbial risk assessment.
  • Testing plausible alternative models is essential to avoid understating uncertainty.
  • Alternative dose-response models can improve predictions, especially when human data are scarce.

Related Concept Videos